2008 (9) TMI 992 - AT - Central Excise

Tribunal Upholds Appellant's Valuation of Physician Samples, Rejects Revenue Challenge

The Tribunal upheld the appellant's valuation of physician samples under Section 4 of the Central Excise Act, 1944, rejecting the Revenue's challenge to ... Valuation of physician samples - transaction value under Section 4(1)(a) - pro rata valuation based on commercial pack versus transaction value - comparability and cost basis under Rule 6(b) - no undervaluation where different packing and distribution channelValuation of physician samples - transaction value under Section 4(1)(a) - pro rata valuation based on commercial pack versus transaction value - Assessable value of physician sample packs sold at the factory gate to wholesale distributors is the transaction value adopted under Section 4(1)(a) and not to be computed on a pro rata basis from the commercial pack where the samples are sold and price is the sole consideration. - HELD THAT: - The Tribunal applied its earlier decision in the same respondents' case and accepted that where physician samples are sold at a value to wholesale distributors for onward free distribution to doctors, a normal transaction value is available and must be adopted under Section 4(1)(a). The Larger Bench decision in the Blue Cross Laboratories matter, which held that assessable value of physician samples cleared free of cost must be determined on a pro rata or comparable/cost basis (Rule 6(b) considerations), was held inapplicable because in Blue Cross the samples were not sold and no transaction value was available. The Tribunal emphasised that differences in packing and distribution channels may justify different prices and that a lower assessable value of sample packs, determined by bona fide sale at the factory gate, does not by itself amount to undervaluation with intent to evade duty; calculation of sample value on a pro rata basis from commercial packs is not supported where transaction value exists and is not shown to be incorrect or impugned.The adjudicating authority's confirmation of demand by computing value of sample packs on a pro rata basis from commercial packs was set aside and the transaction value declared by the appellant for sample packs was held to be the correct assessable value.Final Conclusion: Revenue's appeal is rejected; the transaction value declared for physician sample packs sold at the factory gate must be accepted under Section 4(1)(a) where such sales are genuine, and pro rata valuation from commercial packs is inappropriate in those circumstances. Issues involved: Valuation of physician samples u/s 4 of the Central Excise Act, 1944.The judgment pertains to the valuation of physician samples cleared by the appellant on payment of duty u/s 4 of the Central Excise Act, 1944. The impugned order passed by the Commissioner (Appeals) was challenged by the Revenue. The issue revolved around the difference in prices of sale packs and sample packs, with the adjudicating authority alleging undervaluation of the sample packs. However, the Tribunal noted that both sets of packs were meant for different channels with varying packing patterns, and the prices were correctly determined by the appellants at the factory gate as per Section 4(1)(a) of the Act. The Tribunal referred to a previous decision in the same appellant's case where it was held that the value at which physician samples are sold should be adopted u/s 4(1)(a) unless found incorrect and impugned. The Tribunal set aside the impugned order and allowed all appeals with consequential relief to the appellants, as the issue had already been decided in the appellant's favor in a previous case.In conclusion, the Tribunal found no merits in the Revenue's appeal as the issue had already been decided in the same respondents' case. The appeal was rejected accordingly.